Brain Tumor Diagnosis & Treatment Market Intelligence Report - Global Forecast to 2027

Brain Tumor Diagnosis & Treatment Market Intelligence Report - Global Forecast to 2027

The Global Brain Tumor Diagnosis & Treatment Market is projected to reach USD 2,205.48 million by 2027 from USD 1,482.43 million in 2021, at a CAGR 6.84% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Brain Tumor Diagnosis & Treatment Market size was estimated at USD 591.19 million in 2021 and expected to reach USD 631.57 million in 2022, at a CAGR 6.84% to reach USD 879.54 million by 2027.
• The Asia-Pacific Brain Tumor Diagnosis & Treatment Market size was estimated at USD 375.90 million in 2021 and expected to reach USD 402.63 million in 2022, at a CAGR 6.96% to reach USD 562.90 million by 2027.
• The Europe, Middle East & Africa Brain Tumor Diagnosis & Treatment Market size was estimated at USD 515.32 million in 2021 and expected to reach USD 549.48 million in 2022, at a CAGR 6.76% to reach USD 763.02 million by 2027.

Market Segmentation & Coverage:

The report on brain tumor diagnosis & treatment identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the brain tumor diagnosis & treatment to forecast the revenues and analyze the trends in each of the following sub-markets:

Treatment:

• Chemotherapy
• Immunotherapy
• Radiation Therapy
• Radiosurgery
• Surgery
• Targeted Drug Therapy

Diagnosis:

• CT Scan
• EEG
• Molecular Testing
• MRI
• PET-CT Scan

Type:

• Primary Brain Tumor
• Secondary Brain Tumor

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• Amgen Inc.
• AstraZeneca PLC
• Canon Medical Systems Corporation
• Carestream Health, Inc.
• Eisai Co., Ltd.
• Elekta AB
• GE Healthcare
• Hitachi Medical Systems
• Koninklijke Philips N.V.
• Merck & Co., Inc.
• Pfizer Inc.
• Shimadzu Corporation
• Siemens Healthineers AG
• Varian Medical Systems, Inc.

Currency: USD

Base Year: 2021

Estimated Year: 2022

Forecast Year: 2027

Base Year Value: USD 1,482.43 million

Estimated Year Value: USD 1,583.70 million

Forecast Year Value: USD 2,205.48 million

CAGR (%): 6.84%.

Please Note: PDF & Excel + Online Access - 1 Year